Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 1863 entries
View as:

A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03843775 Org: User:
Start: 02/14/19 End: 09/02/23 Due: 09/02/24

A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.

Phase: N/A Priority: Normal
NCT ID: NCT03755102 Org: User:
Start: 11/21/18 End: 07/07/23 Due: 07/07/24

A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT00589667 Org: User:
Start: 09/30/06 End: 07/31/10 Due: 07/31/11

Patient Communication Training Intervention

Phase: N/A Priority: Normal
NCT ID: NCT00933855 Org: User:
Start: 06/30/09 End: 06/30/11 Due: 06/30/12

T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02350777 Org: User:
Start: 01/21/15 End: 10/25/17 Due: 10/25/18

Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00582478 Org: User:
Start: 10/31/01 End: 12/31/25 Due: 12/31/26

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06370143 Org: User:
Start: 04/11/24 End: 04/11/36 Due: 04/11/37

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06557148 Org: User:
Start: 08/13/24 End: 08/13/27 Due: 08/13/28

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04648904 Org: User:
Start: 11/24/20 End: 11/30/26 Due: 11/30/27

Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography

Phase: N/A Priority: Normal
NCT ID: NCT03430908 Org: User:
Start: 12/22/17 End: 06/17/19 Due: 06/17/20

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Phase: N/A Priority: Normal
NCT ID: NCT04291612 Org: User:
Start: 02/26/20 End: 02/26/26 Due: 02/26/27

Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT00003540 Org: User:
Start: 06/30/98 End: 11/30/02 Due: 11/30/03

The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00588705 Org: User:
Start: 12/31/07 End: 01/31/17 Due: 01/31/18

Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease

Phase: N/A Priority: Normal
NCT ID: NCT05048459 Org: User:
Start: 09/01/21 End: 09/30/26 Due: 09/30/27

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT04544098 Org: User:
Start: 09/02/20 End: 09/30/26 Due: 09/30/27

Trial of Modifications to Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT01407263 Org: User:
Start: 07/31/11 End: 07/31/25 Due: 07/31/26

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02675829 Org: User:
Start: 02/29/16 End: 02/28/26 Due: 02/28/27

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03794635 Org: User:
Start: 12/20/18 End: 12/31/25 Due: 12/31/26

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Phase: N/A Priority: Normal
NCT ID: NCT03877250 Org: User:
Start: 03/08/19 End: 08/26/20 Due: 08/26/21

Measuring Patient Expectations for Thyroid Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01412762 Org: User:
Start: 07/31/11 End: 07/31/25 Due: 07/31/26

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03743662 Org: User:
Start: 11/12/18 End: 11/30/25 Due: 11/30/26

A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03344536 Org: User:
Start: 11/10/17 End: 08/12/21 Due: 08/12/22

Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002919 Org: User:
Start: 11/30/96 End: 01/31/03 Due: 01/31/04

Continued Access to RXDX-105

Phase: N/A Priority: Normal
NCT ID: NCT03784378 Org: User:
Start: 12/14/18 End: 09/30/20 Due: 09/30/21

A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis

Phase: N/A Priority: Normal
NCT ID: NCT03127709 Org: User:
Start: 04/07/17 End: 04/30/26 Due: 04/30/27